Clinical Nuclear Medicine · 2023 · 11 citations · 10 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic RadiologyMetastasisBreast Cancer ImagingLymph Node MetastasisLymphatic MetastasisMalignant NeoplasmsMetastatic Breast CancerPositron Emission TomographyAxillary Lymph Node MetastasisBreast Cancer Metastasis To Lymph NodesFalse Negative DetectionLymph Node Metastasis AssessmentMediastinal Lymph Node MetastasisMetastatic RelapseMetastatic Tumor DetectionSupraclavicular Lymph Nodes
ABSTRACT: A 69-year-old woman with breast cancer underwent 18 F-FDG PET/CT because of the increased CA-15-3 level. 18 F-FDG PET/CT showed multiple hypermetabolic lymph nodes (LNs) in the neck and mediastinum. The patient was also referred for 68 Ga-fibroblast activation protein inhibitor (FAPI) 04 PET/CT for further evaluation. However, 18 F-FDG-avid LNs were FAPI-negative on 68 Ga-FAPI-04 PET/CT. Supraclavicular LN biopsy confirmed the metastasis of breast cancer. Recent reports have focused on the potential of FAPI PET imaging in breast cancer; however, this case highlights that false-negative 68 Ga-FAPI-04-PET/CT findings should also be considered while evaluating metastatic spread.
10